tiletamine hydrochloride has been researched along with epoxyquinomicin c in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Umezawa, K | 1 |
| Koide, N; Lin, Y; Ukaji, T; Umezawa, K | 1 |
| Lin, Y; Umezawa, K | 1 |
3 review(s) available for tiletamine hydrochloride and epoxyquinomicin c
| Article | Year |
|---|---|
Inhibition of tumor growth by NF-kappaB inhibitors.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Cyclohexanones; Drug Design; Humans; Neoplasms; NF-kappa B; Quinones; Signal Transduction; Tumor Cells, Cultured | 2006 |
Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.
Topics: Animals; Antineoplastic Agents; Benzamides; Cyclohexanones; Humans; Neoplasm Metastasis; Neoplasms; NF-kappa B; Quinones | 2018 |
Inhibition of matrix metalloproteinase expression and cellular invasion by NF-κB inhibitors of microbial origin.
Topics: Actinobacteria; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Movement; Cyclohexanones; Glyoxylates; Humans; Matrix Metalloproteinase 11; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Models, Molecular; Neoplasm Invasiveness; Neoplasms; NF-kappa B; NF-kappa B p50 Subunit; Quinones | 2020 |